145 related articles for article (PubMed ID: 12027100)
41. Contact transscleral ciliary body photodynamic therapy in pigmented rabbits using verteporfin and diode laser: evaluation of treatment parameters.
Tsilimbaris MK; Charisis SK; Naoumidi T; Panteleontidis V; Skondra D; Christodoulakis E; Naoumidi I
Curr Eye Res; 2006; 31(7-8):577-85. PubMed ID: 16877266
[TBL] [Abstract][Full Text] [Related]
42. Effects of photodynamic therapy using hematoporphyrin monomethyl ether on experimental choroidal neovascularization.
Fan S; Qiu H; Huang H; Gu Y; Zeng J
Photochem Photobiol; 2010; 86(4):972-80. PubMed ID: 20553408
[TBL] [Abstract][Full Text] [Related]
43. Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells.
Yang C; Liu Q; He D; Na N; Zhao Y; Ouyang J
Analyst; 2014 Dec; 139(24):6414-20. PubMed ID: 25327945
[TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy (PDT) of the ciliary body with silicon naphthalocyanine (SINc) in rabbits.
Hill RA; Garrett J; Reddi S; Esterowitz T; Liaw LH; Ryan J; Shirk J; Kenney M; Shimuzu S; Berns MW
Lasers Surg Med; 1996; 18(1):86-91. PubMed ID: 8850470
[TBL] [Abstract][Full Text] [Related]
45. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser.
Iliaki OE; Naoumidi II; Tsilimbaris MK; Pallikaris IG
Lasers Surg Med; 1996; 19(3):311-23. PubMed ID: 8923426
[TBL] [Abstract][Full Text] [Related]
46. Transpupillary thermotherapy threshold parameters: funduscopic, angiographic, and histologic findings in pigmented and nonpigmented rabbits.
Peyman GA; Genaidy M; Moshfeghi DM; Ghahramani F; Yoneya S; Men G; Kuo PC; Bezerra Y; Nishiyama-Ito Y
Retina; 2003 Jun; 23(3):371-7. PubMed ID: 12824839
[TBL] [Abstract][Full Text] [Related]
47. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update.
Miller GG; Brown K; Ballangrud AM; Barajas O; Xiao Z; Tulip J; Lown JW; Leithoff JM; Allalunis-Turner MJ; Mehta RD; Moore RB
Photochem Photobiol; 1997 Apr; 65(4):714-22. PubMed ID: 9114749
[TBL] [Abstract][Full Text] [Related]
48. [Experimental assessment of the capacities of use of photosense. Communication 2. Photodynamic therapy for epibulbar and choroid tumors].
Budzinskaia MV; Likhvantseva VG; Shevxchik SA; Loshchenov VB; Kuz'min SG; Vorozhtsov GN
Vestn Oftalmol; 2005; 121(5):17-9. PubMed ID: 16274057
[TBL] [Abstract][Full Text] [Related]
49. Vascular effects of photodynamic and pulsed dye laser therapy protocols.
Channual J; Choi B; Osann K; Pattanachinda D; Lotfi J; Kelly KM
Lasers Surg Med; 2008 Nov; 40(9):644-50. PubMed ID: 18951421
[TBL] [Abstract][Full Text] [Related]
50. Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells.
Deininger MH; Weinschenk T; Morgalla MH; Meyermann R; Schluesener HJ
Biochem Biophys Res Commun; 2002 Nov; 298(4):520-30. PubMed ID: 12408983
[TBL] [Abstract][Full Text] [Related]
51. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
52. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
Gohto Y; Obana A; Kanai M; Nagata S; Miki T; Nakajima S
Ophthalmic Surg Lasers; 2000; 31(1):55-60. PubMed ID: 10976562
[TBL] [Abstract][Full Text] [Related]
53. Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.
Li T; Hou X; Deng H; Zhao J; Huang N; Zeng J; Chen H; Gu Y
Photochem Photobiol Sci; 2015 May; 14(5):972-81. PubMed ID: 25793654
[TBL] [Abstract][Full Text] [Related]
54. Photodynamic-induced apoptosis of human nasopharyngeal carcinoma cells using Hypocrellins.
Ali SM; Olivo M; Yuen GY; Chee SK
Int J Oncol; 2001 Sep; 19(3):633-43. PubMed ID: 11494047
[TBL] [Abstract][Full Text] [Related]
55. Biodegradable hypocrellin derivative nanovesicle as a near-infrared light-driven theranostic for dually photoactive cancer imaging and therapy.
Zheng X; Ge J; Wu J; Liu W; Guo L; Jia Q; Ding Y; Zhang H; Wang P
Biomaterials; 2018 Dec; 185():133-141. PubMed ID: 30243149
[TBL] [Abstract][Full Text] [Related]
56. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells.
Jiang Y; Leung AW; Wang X; Zhang H; Xu C
Int J Radiat Biol; 2014 Jul; 90(7):575-9. PubMed ID: 24661233
[TBL] [Abstract][Full Text] [Related]
57. Butylamino-demethoxy-hypocrellins and photodynamic therapy decreases human cancer in vitro and in vivo.
Xu S; Chen S; Zhang M; Shen T; Zhao Y; Liu Z; Wu Y
Biochim Biophys Acta; 2001 Nov; 1537(3):222-32. PubMed ID: 11731224
[TBL] [Abstract][Full Text] [Related]
58. Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits.
Hill RA; Crean DH; Doiron DR; Ghosheh F; Ryan JA; Kelly H; Booth M; Liaw LH; Newman L; Berns MW
Ophthalmic Surg Lasers; 1997 Nov; 28(11):948-53. PubMed ID: 9387183
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of hypocrellin pharmacokinetics in phototherapy.
Ali SM; Olivo M
Int J Oncol; 2002 Dec; 21(6):1229-37. PubMed ID: 12429972
[TBL] [Abstract][Full Text] [Related]
60. [Russian photosensitizer radachlorine in photodynamic therapy for epibulbar and choroid tumors: experimental studies].
Avetisov SE; Likhvantseva VG; Reshetnikov AV; Fedorov AA; Vereshchagina MV; Balaian ML; Krupnov RN
Vestn Oftalmol; 2005; 121(5):9-13. PubMed ID: 16274055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
